Trials / Unknown
UnknownNCT06322303
Effect of Cannabidiol (CBD) on Vision and Driving
Effect of Cannabidiol (CBD) Consumption on Visual Function and Driving Performance
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Universidad de Granada · Academic / Other
- Sex
- All
- Age
- 18 Years – 43 Years
- Healthy volunteers
- Accepted
Summary
The use of cannabis with ∆9-tetrahydrocannabinol (THC) content has been shown to have negative effects on vision and driving. The use of other cannabinoids, such as cannabidiol (CBD), which is not attributed with a psychoactive effect, is increasing significantly. This project aims to investigate whether consuming CBD can negatively affect visual function by assessing a wide range of visual parameters and whether these changes may pose a risk for everyday activities such as driving.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Placebo (CBD 0%) | Participants are required to vaporize placebo at 0% CBD concentration |
| OTHER | CBD 15% | Participants are required to vaporize CBD at a concentration of 15%. |
| OTHER | CBD 30% | Participants are required to vaporize CBD at a concentration of 30%. |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2023-09-30
- Completion
- 2025-12-31
- First posted
- 2024-03-21
- Last updated
- 2024-03-22
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06322303. Inclusion in this directory is not an endorsement.